Keep up to date on the latest medical news at MDLinx - FREE!

  • Stay current on the latest medical literature, research and clinical news
  • MD jobs and physician job search at our new medical job Career Center
  • Receive invitations to paid market research
  • Search Clinical Trials and Medical Conferences

register to view free medical at articles at MDLinx

Follow Us

Posts by category

MDLinx Blog - Medical News and more.

Current Articles | RSS Feed RSS Feed Sets New Industry Standard with Launch of International Physician Verification Program


Drives Client and Physician Confidence by Raising the Verification Bar for Physicians Worldwide

MDLinx, part of the M3 Group, and the number one physician specialty website in the US, with the largest single site for healthcare professionals in the EU and the Nordics, breaks new ground with the introduction of their international physician verification program.

“Most physician websites are built in one language, for one country and verify physicians country by country in verification silos, with no global standards evident,” comments Craig Overpeck, CTO of MDLinx and COO of M3 Global Research. “Our new international verification program is an M3 First, reaching out globally to all physicians who use our MDLinx platform, engaging them in their language and credentialing with diplomas or licenses. The ultimate goal is to insure we have the most verified physician panel for opt-in market research and to communicate our pharma content directly to the intended subscribed physician audience… out of the reach of non-physicians."

This new international verification program is indicative of the M3 Group corporate DNA that values the relentless pursuit of accuracy and credibility for their physician members and their valued, expanding global client base.

“We have been verifying physicians for years in the US, G5, Japan, Russia, Korea, and China,” adds Mr. Overpeck. “As we move into more countries where there is not a central database of physicians, we saw the need to clearly show which physicians are verified and which are not. That’s why this verification initiative is integral to our continued global expansion.”

Recently was named “Best Healthcare Professional Media Brand” by the prestigious trade publication Medical Marketing and Media.


Our new international verification program is an M3 First, reaching out globally to all physicians who use our MDLinx platform, engaging them in their language and credentialing with diplomas or licenses.

Craig Overpeck, CTO of MDLinx and COO of M3 Global Research more medical news articles to Award Unprecedented Half Million Dollars of Online Advertising

 to Award Unprecedented Half Million Dollars of Online Advertising through New Contest Educating Primary Care Physicians about Worthy Cause

MDLinx Primary Cares Challenge for Charity Launched at ePharma Summit, Unique Opportunity for Pharma or Pharma Agencies to Showcase Creativity to Benefit Favorite Charity. Winner to Be Announced at the 25th Anniversary Med Ad News Manny Awards.


MDLinx, (, a part of M3 Group, a leading provider of online marketing solutions to the healthcare industry, is spreading the love of charity this Valentine’s week by launching the MDLinx Primary Cares Charity Challenge. This creative contest is open to pharma and pharma agencies that are encouraged to compete for up to $500,000 worth of free online advertising for a favorite charity. Judging is based on the creative submission of an education campaign discussing the mission of the chosen charity, which is specifically tailored for an audience of Primary Care Physicians. The winning entrant’s charity will be advertised on, where healthcare professionals find the most up-to-date, valuable clinical and medical information available, helping them make the most informed decisions for their patients. (More information and complete rules found at

“M3 Group, of which is a part of, has experienced tremendous growth, remarked Jack Bilson,” VP of M3 Group. “We now reach over 2.5 million physicians through our global health care professional networks and nearly 600,000 physicians in the Unites States alone. MDLinx which has long been the #1 physician specialty site in the United States, and has added a number of new services which has helped us grow substantially in many ways including our reach with Primary Care Physicians. Overall, this contest is a way for us to continue to give back and share our success through supporting a worthy charity with a specific focus on reaching our large, and growing, Primary Care Physician audience.”

Recently, M3 Group created another charitable initiative to help with the Philippines Tsunami Recovery through M3 Global Research, the only ISO certified research panel in Europe and ISO certified in the US, as well.

“We are thrilled to enter this creative and charitable contest,” commented Wendy White, Founder and CEO of Siren Interactive, a rare disease marketing agency. “This gives us the possibility to reach and educate a huge primary care physician audience about a non-profit derived tool that will speed time to diagnosis for rare diseases. It’s a remarkable opportunity.”

“I am very excited to participate in this challenge that will have a positive impact and that combines all my favorite things – healthcare, digital, and advertising,” comments Lisa Flaiz, Group Product Director, Digital Marketing, Janssen, Pharmaceutical Companies of Johnson and Johnson. “I am pleased to have the opportunity to review the many deserving entries as part of the judging panel – I know this will be a difficult decision but I am looking forward to helping to deliver good news to a deserving cause!” All entries are to be submitted online at, by April 14th.

Judging for the contest will be in two phases.

  • Phase #1: Up to four Finalists will be chosen by a panel of industry experts, digital thought leaders in online advertising space.
  • Phase #2: Winner is chosen from among the Finalists by an MDLinx panel of 1000 Primary Care Physicans, part of the MDLinx ISO certified HCP Panel, the largest of its kind in the world.

For both Phase #1 and Phase #2, judging is based equally on these three criteria:

  • Charitable Organization’s important work/goals/needs
  • Creative execution of strategy
  • Comprehensive/diverse use of MDLinx solutions in campaign

The entry with the highest score will be deemed the first prize winner, the entry with the next highest score will be deemed the second place winner, and the entry with the next highest score will be deemed the third place winner, all three subject to verification of eligibility and compliance with the Official Rules.

Winner of the MDLinx Primary Cares Challenge for Charity will be announced live at the 25th Anniversary Med Ad News Manny Awards on April 24th in New York City. “The healthcare marketing space has a rich tradition of philanthropic endeavors which MDLinx has captured with this exciting new contest,” comments Daniel Becker, Owner, Brand Director, Med Ad News, “It’s a natural extension of our Manny Awards program that has long emphasized agency participation in a diverse array of charitable causes, and we’re grateful for the opportunity to help showcase those efforts.”


More information and complete rules found at

Super Weekend for Physicians Looking for New Positions?


Super Weekend for Physicians Looking for New Positions?, Largest Healthcare Professional Site with a Career Center, Polls Physicians on their Big Game Weekend Plans for Career Moves

Matt Baker, MDLinx Director of Physician Recruitment Advertising

We reach nearly 600,000 physicians in the US alone, and noticed a trend of high volume traffic to our career site around the holidays and national events. We did the research to see who planned to explore career options this big game weekend.

January 31, 2014

Come Sunday, there will be plenty of moves on the football field, but MDLinx, (, a part of M3 Group, a leading provider of online marketing solutions to the healthcare industry, is more interested in seeing what moves healthcare professionals are looking to make.

“Physicians visit to stay current on the latest, most important medical news and information, and to explore new career opportunities at our career center, (,” comments Matt Baker, MDLinx Director of Physician Recruitment Advertising. “We reach nearly 600,000 physicians in the US alone, and we noticed a trend toward a high volume of traffic to our career site around the holidays, as well as national events, when busy healthcare professionals may have some free time. We thought it would be interesting to get a snapshot of those who plan to explore new career options during the big game weekend. So we did the research.”

A snap poll of 1061 health care professionals was taken over the last 72 hours by the ISO certified Research Panel of M3 Global Research,, also a part of M3 Group. The study revealed that 15% of healthcare professionals surveyed said they would look for jobs in their specialty or region over the big game weekend.

"These numbers are not surprising to hear,” says Jennifer Metivier, M.S., FASPR, Executive Director, Association for Staff Physician Recruiters, (ASPR). “The ASPR In-House Physician Recruitment Benchmarking Report identified a trend of increasing physician turnover rates over the last few years, which may correlate to the improving housing market and economy. Physicians are more likely to be in a position to seek new opportunities given these economic indicators."

“Job satisfaction is often a topic of discussion when family and friends get together, like they will this Sunday,” remarks Matt Baker. “This confirmed our thinking that even during the weekend festivities, many physicians may indeed look to score that new big career opportunity.”

MDLinx Career Center

Doctors, Are you aware the effects Social Media has on your career

Facebook Twitter LinkedIn Google Plus

Doctors, are you aware of the effects of social media on your career?


As the use of social media continues to grow, how does this affect doctors? As a general rule of thumb, doctors should always proceed with caution when using social media.

social media and physiciansDoctors should always be conscious about what they and others are posting on social networks, blogs, and other websites. This includes images, comments, and friendship requests on social media. Common concerns of doctors include complaints and allegations made about doctors by patients on social networking sites, friendship requests from patients, and doctors who had found themselves in difficulties after posting comments and images online.

Social media can help doctors to network more effectively and give patients more access to healthcare information. But there are risks too, particularly when it comes to confidentiality. Doctors should be aware that social media sites such as Twitter and Facebook are informal environments, so it is easy for doctors to let their guard down and not follow the same rules as they would offline. However, the rules of confidentiality apply as much when posting online as they do to when you are chatting to a friend on a night out. Not only do the same rules apply online, but it is also important that doctors remember that when something is shared through social media, it may not just be their friends and family who see it, and could potentially be shared with strangers too.

>> List jobs in MDLinx Career Center, and let us do the work for you.
Contact us for listing packages and competitive pricing. We’ll help you find the best candidates.

>>Sign up to receive the free MDLinx Career Center newsletter.
You’ll receive a weekly summary of job recommendations right in your email inbox. You must be registered on MDLinx to take advantage of this member perk, too. Once you’re logged in, simply find the Edit Newsletter Subscriptions tab under My Account and check the box for Career Center Newsletter.


Smartest Gastroenterologist daily quiz competition is now live. Play today!

Facebook Twitter LinkedIn Google Plus

NOW LIVE!  Smartest Gastro

Smartest Gastroenterologist daily quiz competition is now live. Play today!

Buried in literature?

Compete for the title of Smartest Gastroenterologist in America. Set aside 60 seconds today to keep your brain sharp.

The US Physician with the most points each month is named the Smartest Gastroenterologist in America.

The Smartest Gastroenterologist is a 1-minute daily quiz that makes keeping up with the literature both fun and competitive.

  • Answer up to 5 clinical questions on a varying topic each weekday to accumulate points.
  • Get your instant score and ranking versus others who played that day.
  • Follow the live leader boards online to see which US physicians came out on top.
  • See where your medical school alma mater ranks in the competition by following the Alumni Challenge leader board.

► Start Now

Receive a personalized trophy, e-certificate and national recognition. Make it into the Top 10 to receive an e-certificate and a small token of our congratulations. The Top 100 also get e-certificates and bragging rights.


Are your patients protected in clinical trials?


MDLinx Clinical Trials Navigator





Are your patients protected in clinical trials?

Legislation to protect subjects in clinical trials introduced

Legislation designed to protect clinical trial study participants, close dangerous loopholes, and bring certainty and public transparency to life–saving research studies, has been introduced, according to a statement by the bill’s sponsors. The Trial and Experimental Studies Transparency (TEST) Act of 2013 updates and expands, the clinical trial registry data bank with stronger reporting requirements, and requires that all foreign clinical studies meet the same registration and reporting requirements as domestic trials if they are used to support an application to market a product in the United States. Eighty percent of the drugs entering the U.S. market in 2008 were clinically tested overseas and a growing number of device trials are also moving abroad. Many of these trials are not required to be registered with the clinical trials database.

>> Use our ultra-fast clinical trial search tool to locate the US trials in your location. Find the sponsor, stage, rating and (NEW!) related articles.

>> Sign up for the Clinical Trials Newsletter to stay current on the trials taking place in your area. Choose the Edit Newsletter Subscriptions tab and check the box under Clinical Trials Newsletter clinical trials

Just for you...A quiz focused on the Affordable Care Act (ACA)


One Day Only!
Test your knowledge about the Affordable Care Act

The Smartest Doc is bringing you, a quiz focused on the Affordable Care Act (ACA).

The face of insurance is changing, to help you keep pace, The Smartest Doc has scheduled a quiz today, November 26, about the ACA. We cover

  • Deadlines for your patients who want to enroll
  • Tax implications for those who don’t
  • And look at a host of other details.

Register and play today—all the points you earn will help you win the title of Smartest Doc in America! Be sure to join us: TODAY!

► Play Now
Buried in literature?

*DID YOU KNOW? Family Medicine Board Exam Prep course is now live with 100 board-style questions! Join MDLinx today and Prepare to pass without paying to prepare!


How Practices Should Deal With Late Patients


Most medical practices have policies about no-show patients, but does your practice have a clear protocol for patients who show up late to appointments? How about the chronically late patients for whom tardiness has come to be expected?

A tardy patient can easily derail a practice’s whole schedule. Especially in small practices where there is less coverage, one late patient can affect the amount of time all patients receive that day. Do you accommodate the patient? Turn him away? What are the effects of either option?

There can be major liability issues with refusing to see a late patient outright. “It can be downright unethical,” states Torrieri. It is recommended to discuss this with your malpractice carrier. Unfortunately, if a medical emergency were to occur as your late patient is asked to leave your office, you can be held responsible.

The right thing to do is try to accommodate the patient. First, be sure that your practice is running on time before penalizing a patient for being late. "If you're five minutes late, everyone is five minutes late," cites the article. If another clinician is available, fit the patient into her schedule instead. If there is no available coverage, let the patient know the approximate length of time until he can be seen.

For chronic lateness, you may decide to dismiss the patient from your care if the behavior is addressed and does not change. Here is an example from the article on an escalating tardiness policy:

At Performance Pediatrics in Plymouth, Mass., late patients — those who are more than five minutes late — are treated the same as no-show patients. On the first and second offenses, they're sent a warning letter. On the third offense, they're told they will be dismissed if the problem continues. And on the fourth offense, they are asked to find another provider.

describe the image

Increase in A.D.H.D. Cases Gaining Attention in U.S.


A shortage hit the United States between the fall of 2011 and the spring of 2012 that brought attention to the condition of the country’s mental health.  A.D.H.D. medications, especially low dose generic brands were hit by the growing pool of patients being diagnosed with the disorder. According to the MDLinx article entitled, The Not-So-Hidden Cause Behind the A.D.H.D. Epidemic “Before the early 1990’s, fewer than 5 % of school aged kids were thought to have A.D.H.D. Earlier this year, data from the Centers For Disease Control and Prevention showed that 11 % of children ages 4 to 17 had at some point received the diagnosis – and that doesn’t even include first time diagnosis in adults.”This story examines the surge in demand and the expert’s theories as to the increase.

Although there is no clear cut answer to the uptick in A.D.H.D.  diagnoses; experts in the field have offered a series of correlating  theories.  One of these experts, Adam Rafalovich, a sociologist at Pacific University in Oregon provided two explanations. The first being the inclusion of A.D.H.D. into the Individuals With Disabilities Education Act in 1991. This Act allowed access to tutors as well as time allowances on standardized tests. Secondly, the overhaul of the Food and Drug Administration in 1997 which allowed drug companies to more freely market directly to the public.  

Stephen Hinshaw, a professor of psychology at University of California, Berkeley put forth a different explanation.  While examining the origin of the increase he noticed a disparity in the disorder diagnosis frequencies between two states; North Carolina and California. North Carolina reported a staggering 15.6% of their children diagnosed versus California’s modest 6.2%. Upon further analysis, demographics such as race and income yielded no strong outliers. Struggling to pinpoint the main culprit, Hinshaw finally indentified educational policy as a possibility. Continued investigation into the role of educational policy found correlative evidence. In particular, evidence pointed to the institution of the No Child Left Behind Act as the catalyst behind the inflation of A.D.H.D. cases.  The groundbreaking Act was enacted to reward schools who achieved academic benchmarks.  North Carolina among other states were quick to adopt the program while California followed suit later. As states started to impose positive and negative sanctions Hinshaw noted an A.D.H.D. increase in those states not long after.  Subsequently, four years later the Act’s implementation the U.S. saw a 22% increase of A.D.H.D. diagnoses.  

The A.D.H.D. upswing in not strictly a U.S. phenomenon. Historically, Europe has employed the use of a much stricter set of guidelines than their U.S. counterpart. In return their A.D.H.D. case frequencies were humble in comparison. However, recently the U.S. has been exporting their disorder definitions and the medical responses worldwide.  Consequently Europe’s numbers have risen; although not quite to the extent of the United States.

Keep up daily with the latest Psychiatry news articles at - more Psychiatry news articles

M3 Launches PDR® Powered by MDLinx, Extends Reach to Nearly 600,000 Physicians in U.S.


Expanded clinical information website offering now available to PDR members creates new opportunities for M3’s customers in healthcare professional promotion, market research and physician employment.

(Washington, DC, November 18th, 2013) The award winning MDLinx content, (, is now offered as membership benefit to all PDR’s members.  Through this tightly integrated partnership with PDR, (, M3 is now capable of reaching nearly 600,000 US physicians on behalf of its customers in brand marketing, market research, and physician recruiting.   

“PDR is a one-of-a-kind brand, trusted by physicians to deliver highly relevant drug information,” remarked Aki Tomaru, CEO of M3 USA. “MDLinx has been the leading website for U.S. specialty physicians.  With the launching of PDR Powered by MDLinx, (, M3 adds 330,000 US physicians, significantly extending our reach in key specialties such as primary care, psychiatry, urology and pediatrics.  Combined with our existing industry leading coverage in oncology, rheumatology and endocrinology, our HCP reach may be the best to the specialties that matter most to both Pharmaceutical and Life Science companies. This represents a tremendous opportunity for our customers.”    

 “We are thrilled to partner with MDLinx, as PDR continues to expand our HCP offerings,” comments Rich Altus, President of PDR. “Their practical medical information can now be found right on our site, PDR Powered by MDLinx. This powerful offering will provide even more reasons for prescribers to rely on PDR for the most relevant drug and clinical information inside and outside of workflow.” PDR continues to lead the industry by providing drug information and patient support inside the physician’s Electronic Health Record (EHR).

MDLinx is the most actively used website among HCPs today. Now with the PDR partnership in place, M3 offers the greatest reach in the industry to its customers. This is M3 Group’s second industry leading partnership inked in just over two months, the last being an integration with MMIT, to deliver market access information directly to Healthcare Providers.

“We are committed to helping HCPs get the latest medical information available to help them make the most informed prescribing decisions for their patients,” remarks Tomaru. “The PDR partnership is the next great step in our continued growth strategy in the United States.”

About M3 Group
The M3 Group operates in the US, Asia, and Europe with over 5 million physician members globally via its physician websites such as,, and M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul.

M3 Group Links


About PDR Network


PDR Network is the nation’s leading aggregator and distributor of FDA-approved drug safety information and patient support services, reaching healthcare providers directly through the Physicians’ Desk Reference® suite of digital and print services. PDR® Communications provides direct access to more than one million healthcare professionals with both promotional and clinical vehicles. Healthcare professionals access trusted PDR content across channels, including via the Physicians’ Desk Reference (PDR), the most recognized drug information reference available in the U.S., now available in multiple formats; PDR interactive drug services for Electronic Health Record (EHR) systems;®, the online home of the PDR; and mobilePDR® for handheld devices.  The PDR Pharmacy Discount Card helps patients afford their medications – is a free service to physicians and their patients.  For more information on our products and services, please visit

PDR Network Links - more medical news articles

All Posts

Trending Medical Articles

Friday, Apr 11, 2014
Annals of Rheumatic Diseases, 04/11/2014 Banka S, et al. – Leri’s pleonosteosis (LP) is an autosomal dominant rheumatic condition characterised by flexion contractures of the interphalangeal joints, limited motion of multiple joints, and short broad metacarpals, metatarsals and phalanges. Scleroderma–like skin thickening can be seen in some individuals with LP. The authors...Read More
Friday, Mar 28, 2014
The Journal of Heart and Lung Transplantation, 03/28/2014 Nair N, et al. – Cancers in post–transplant patients exhibit the same molecular and cellular properties as those in their non–transplanted counterparts and arise secondary to uncontrolled/sustained growth, apoptosis resistance, inhibition of tumor suppressors, immortalization of cells with invasion, and metastasis. The...Read More
Thursday, Apr 10, 2014
European Journal of Nuclear Medicine & Molecular Imaging, 04/10/2014 Hesse S, et al. – Modulation of the immune system by the CNS may involve serotonergic regulation via the brain serotonin transporters (SERT). The objective of the study was to assess the availability of SERT in antidepressant–naive patients with MS by means of PET. Serotonergic neurotransmission in MS patients is...Read More
Friday, Apr 11, 2014
Biological Psychiatry, 04/11/2014 Hajek T, et al. – Type 2 diabetes mellitus (T2DM), but also prediabetes, may be risk factors for prefrontal neurochemical alterations in bipolar disorder (BD). These changes were associated with poor psychosocial functioning and could indicate impaired energy metabolism. The findings emphasize the importance of improving diabetes care in BD and suggest...Read More
Thursday, Apr 10, 2014
Critical Care, 04/10/2014 Ruan SY, et al. – The study aimed to explore the grounds for the inconsistent results in previous studies and update the evidence. The effects of corticosteroids on the mortality of ARDS differed by duration of outcome measures and etiologies. Corticosteroids did not improve longer–term outcomes and may cause harm in certain subgroups. Current data do not...Read More